Clinically relevant drug interactions with antiretroviral agents

Antiviral Therapy

Volumn 2, Issue 3, 1997, Pages 149-165

  Burger, David M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIHISTAMINIC AGENT; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; ANTIPARASITIC AGENT; ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; AZITHROMYCIN; CARBAMAZEPINE; CLARITHROMYCIN; DELAVIRDINE; DIDANOSINE; DISULFIRAM; FLUCONAZOLE; GANCICLOVIR; IFOSFAMIDE; INDINAVIR; KETOCONAZOLE; LAMIVUDINE; NEVIRAPINE; PROCHLORPERAZINE; PROTEINASE INHIBITOR; PSYCHOTROPIC AGENT; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STEROID; UNINDEXED DRUG; ZALCITABINE; ZIDOVUDINE;

DRUG INTERACTION; DRUG MECHANISM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PHARMACODYNAMICS; PHARMACOKINETICS; PRIORITY JOURNAL; REVIEW;

ANTI-HIV AGENTS; ARYL HYDROCARBON HYDROXYLASES; CYTOCHROME P-450 CYP2D6; CYTOCHROME P-450 CYP3A; CYTOCHROME P-450 ENZYME SYSTEM; DRUG INTERACTIONS; HIV INFECTIONS; HUMANS; OXIDOREDUCTASES, N-DEMETHYLATING;

EID: 0030870736     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (5)

1. Preston SL, Postelnick M, Purdy BD, Petrolati J, Aasi H & Stein DS. Drug interactions in HIV positive patients initiated on protease inhibitors. 4th Conference on Retroviruses and Opportunistic Infections, 22-26 January 1997, Washington DC, US A. Abstract 610.
2. Burger DM, Meenhorst PL & Beijnen JH. Concise overview of the clinical pharmacokinetics of dideoxynucleoside antiretroviral agents. Pharmacy World and Science 1995; 17:25-30.
3. Murphy RL & Montaner J. Nevirapine: a review of its development, pharmacological profile and potential for clinical use. Expert Opinion in Investigational Drugs 1996; 5:1183-1199.
4. Cheng C-L, Smith DE, Cox SR, Watkins PB, Blake DS, Carver PL, Kauffman CA, Meyer K, Amidon GL & Stetson PL. Steady-state (SS) pharmacokinetics (PK) of delavirdine (DLV) in H1V+ patients: in vivo effect of DLV on the erythromycin breath test (ERMBT). 36th Interscience Conference on Antimicrobial Agents and Chemotherapy, September 1996, New Orleans, USA. Abstract A057.
5. Akbari B, Shelton MJ, Adams JM, Hewitt RG & Morse GD. Effects of Helicobacter pylori (HP) treatment on gastric pH and delavirdine mesylate (DLV) pharmacokinetics in HIV+ patients with gastric hypoacidity (GH). 36th Interscience Conference on Antimicrobial Agents and Chemotherapy, September 1996, New Orleans, USA. Abstract A056.